The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Correlation of DNA methylation signatures with response to immune checkpoint inhibitors in metastatic melanoma.
 
Julia Maria Ressler
Honoraria - Amgen; Bristol-Myers Squibb; Novartis
Travel, Accommodations, Expenses - Bristol-Myres Squibb; Roche
 
Erwin Tomasich
No Relationships to Disclose
 
Teresa Hatziioannou
No Relationships to Disclose
 
Helmut Ringl
No Relationships to Disclose
 
Gerwin Heller
No Relationships to Disclose
 
Rita Silmbrod
No Relationships to Disclose
 
Nina Zila
No Relationships to Disclose
 
Philipp Tschandl
Honoraria - FotoFinder; Lilly O.; Novartis
 
Christoph Hoeller
Honoraria - Bristol Myers Squibb Foundation; MSD; Novartis; Pierre Fabre; Sanofi
Consulting or Advisory Role - Almirall Hermal GmbH; Bristol Myers Squibb Foundation; Immunocore; MSD; Novartis; Pierre Fabre; Sanofi
Research Funding - Amgen (Inst); Bristol Myers Squibb Foundation (Inst); MSD (Inst); Nektar (Inst); Novartis (Inst); Pierre Fabre (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Bristol Myers Squibb Foundation (Inst); MSD (Inst); Pierre Fabre (Inst); Sanofi (Inst)
 
Anna Sophie Berghoff
Consulting or Advisory Role - AstraZeneca
Research Funding - Bristol-Myers Squibb (Inst); Daiichi Sankyo Europe GmbH (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Roche
 
Matthias Preusser
Honoraria - Abbvie; Adastra Pharmaceuticals; AstraZeneca; Bayer; BMJ Journals; Bristol-Myers Squibb; CMC Contrast; Daiichi Sankyo; Gan & Lee; Gerson Lehrman Group; GlaxoSmithKline; Lilly; Medahead; MedMedia; Merck Sharp & Dome; Mundipharma; Novartis; Roche; Sanofi; Tocagen
Consulting or Advisory Role - AbbVie; Bristol-Myers Squibb; CMC Contrast; Gerson Lehrman Group; GlaxoSmithKline; Mundipharma; Novartis; Roche
Research Funding - AbbVie (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); GlaxoSmithKline (Inst); Merck Sharp & Dohme; Roche (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; GlaxoSmithKline; MSD; Mundipharma; Roche